(Q37904182)

English

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

scientific article published on July 18, 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces (English)

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

dry powder inhaler

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21782866

7 December 2024

author name string

Qi Tony Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

David A. V. Morton

2

0000-0002-1491-6517

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21782866

7 December 2024

language of work or name

0 references

publication date

18 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0169409X11001955?httpAccept=text/xml

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

https://api.elsevier.com/content/article/PII:S0169409X11001955?httpAccept=text/plain

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Advanced Drug Delivery Reviews

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

275-284

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics

1

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Novel alternative methods for the delivery of drugs for the treatment of asthma

2

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Review of dry powder inhalers

3

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations

4

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Active and intelligent inhaler device development.

6

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Design of fine particles for pulmonary drug delivery

9

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance.

10

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Optimisation of powders for pulmonary delivery using supercritical fluid technology

11

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate.

12

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations

13

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Large porous particles for pulmonary drug delivery

14

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The influence of dose on the performance of dry powder inhalation systems

15

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats

16

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate

17

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates

18

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Preparation of dry powder inhalation by surface treatment of lactose carrier particles

19

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed.

20

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate

21

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Suppression of agglomeration in fluidized bed coating I. Suppression of agglomeration by adding NaCl

22

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".

24

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating

31

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC.

34

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Synthesis of engineered particulates with tailored properties using dry particle coating

35

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Mechanical methods for dry particle coating processes and their applications in drug delivery and development

37

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders

39

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach

40

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The role of force control agents in high-dose dry powder inhaler formulations

41

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Application and mechanism of inhalation profile improvement of DPI formulations by mechanofusion with magnesium stearate

42

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Inverse gas chromatographic method for measuring the dispersive surface energy distribution for particulates

44

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism?

45

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Use of surface energy distributions by inverse gas chromatography to understand mechanofusion processing and functionality of lactose coated with magnesium stearate

46

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating

47

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach

50

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties

51

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate

52

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate

53

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier

54

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200)

55

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Preparation of monolayer particle coated powder by the dry impact blending process utilizing mechanochemical treatment

56

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders

62

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Surface analysis of new chlorpromazinium plastic membrane electrodes

65

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Application of Raman microscopy and band-target entropy minimization to identify minor components in model pharmaceutical tablets

66

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Recent pharmaceutical applications of Raman and terahertz spectroscopies

67

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

TOF-SIMS Characterization and Imaging of Controlled-Release Drug Delivery Systems

68

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS.

71

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

An analysis of the surface chemical structure of polymethacrylate (Eudragit) film coating polymers by XPS

73

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Synthesis and characterization of surface-hydrophobic ion-exchange microspheres and the effect of coating on drug release rate

75

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.

79

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Inhalation drug delivery devices and emerging technologies

81

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Dry powder inhalers (DPIs)--a review of device reliability and innovation

82

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations

83

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation

85

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems

87

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI.

88

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations

89

1 reference

10.1016/J.ADDR.2011.07.002

https://api.crossref.org/works/10.1016/J.ADDR.2011.07.002

7 December 2024

Identifiers

10.1016/J.ADDR.2011.07.002

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37904182&oldid=2284660356"